Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.37 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.37 |
| ▸ | MVD | P53602 | 3/20 | 0.37 |
| ▸ | PGK1 | P00558 | 1/20 | 0.36 |
| ▸ | PGK2 | P07205 | 1/20 | 0.36 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.36 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.36 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.36 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.36 |
| ▸ | FDPS | P14324 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9332834 | 0.98 | BTN3A1 (0.43) | BTN3A1SMN1; SMN2LPAR1LPAR3MVD | |
| SCHEMBL5903139 | 0.98 | BTN3A1 (0.43) | BTN3A1SMN1; SMN2LPAR1LPAR3MVD | |
| SCHEMBL9332362 | 0.98 | BTN3A1 (0.43) | BTN3A1SMN1; SMN2LPAR1LPAR3MVD | |
| SCHEMBL8078762 | 0.98 | BTN3A1 (0.43) | BTN3A1SMN1; SMN2LPAR1LPAR3MVD | |
| SCHEMBL8589837 | 0.96 | PGK1 (0.42) | BTN3A1SMN1; SMN2LPAR1LPAR3PGK1 | |
| SCHEMBL888511 | 0.96 | BTN3A1 (0.42) | BTN3A1SMN1; SMN2LPAR1LPAR3MVD | |
| SCHEMBL30148756 | 0.87 | SMN1; SMN2 (0.46) | SMN1; SMN2PGK1PGK2P2RY2P2RY4 | |
| SCHEMBL12284729 | 0.87 | SMN1; SMN2 (0.46) | SMN1; SMN2PGK1PGK2P2RY2P2RY4 | |
| SCHEMBL29708086 | 0.87 | SMN1; SMN2 (0.46) | SMN1; SMN2PGK1PGK2P2RY2P2RY4 | |
| SCHEMBL579431 | 0.87 | SMN1; SMN2 (0.46) | SMN1; SMN2PGK1PGK2P2RY2P2RY4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122029177-A | Oligonucleotides containing multiple ligands and/or lipids | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122029176-A | Containing a plurality of oligonucleotides modified oligonucleotides | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-116731466-A | ABS plastic particles and preparation process thereof | 江苏银科塑料技术研发有限公司 | 2023-09-12 | — | — | CN | claimed |
| CN-107109441-A | The fermentation process that glycerine and acetic acid conversion are improved | 帝斯曼知识产权资产管理有限公司 | 2017-08-29 | — | — | CN | claimed |
| CN-105492599-A | Glycerol and acetic acid converting yeast cells with improved acetic acid conversion | DSM IP ASSETS BV | 2016-04-13 | — | — | CN | claimed |
| US-20130018006-A1 | Atheroscleroclastic Bioceutical Formulations | KING STEPHEN (US) | 2013-01-17 | — | — | US | claimed |
| US-6787525-B1 | METHOD OF TREATING HIV INFECTIONS AND/OR CANCER DISEASES | SCHOTT HERBERT (DE) | 2004-09-07 | — | — | US | claimed |
| EP-1135401-B1 | GLYCERYL NUCLEOTIDES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE | SCHOTT HERBERT (DE) | 2003-06-18 | — | — | EP | claimed |
| EP-0350973-B1 | Means and product for the diagnosis and therapy of tumours and for the treatment of weaknesses of the cellular and humoral immune system | EHRENFELD UDO (DE) | 1997-11-05 | — | — | EP | claimed |
| CN-1015512-B | TANGENTIAL FLOW AFFINITY ULTRAFILTRATION | HEMOSOL INC (CA) | 1992-02-19 | — | — | CN | claimed |
| US-5021234-A | Agent and product for the diagnosis and treatment of tumors and for the treatment of weaknesses of the cellular and humoral immune defense | EHRENFELD UDO (DE) | 1991-06-04 | — | — | US | claimed |
| CN-87100660-A | TANGENTIAL FLOW AFFINITY ULTRAFILTRATION | — | 1988-01-27 | — | — | CN | claimed |
| JP-56087590-A | — | — | None | — | — | JP | disclosed |
| CN-122028913-A | Oligonucleotides containing ligands in nucleobases, 2 'or 3' positions | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-122029176-A | Containing a plurality of oligonucleotides modified oligonucleotides | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-122029177-A | Oligonucleotides containing multiple ligands and/or lipids | 阿达尔克斯制药有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-1030425-A | Through pasteurization disinfectant, cryodesiccated hemoglobin-based blood substitute | JEN CHANG HSIA (CA) | 1989-01-18 | — | — | CN | disclosed |
| CN-87100660-A | TANGENTIAL FLOW AFFINITY ULTRAFILTRATION | — | 1988-01-27 | — | — | CN | disclosed |
| JP-S5687590-A | DIPHOSPHOGLYCERINE DERIVATIVE | YOSHITOMI PHARMACEUT IND LTD | 1981-07-16 | — | — | JP | disclosed |
| US-4165392-A | MILK PROTEIN, PRESTABILIZING WITH AN ACID AND FURTHER STABILIZING WITH A BRINE SOLUTION CONTAINING A SODIUM, POTASSIUM OR CALCIUM SALT | KURARAY CO., LTD. (JP) | 1979-08-21 | — | — | US | disclosed |